Safety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Clinical trial NCT07263139 · RECRUITING
Trial details
- NCT number
- NCT07263139
- Sponsor
- Agiana Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-02
- Primary completion
- 2027-06-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.